Drug General Information |
Drug ID |
D0P3IZ
|
Former ID |
DIB007231
|
Drug Name |
E-2040
|
Indication |
Schizophrenia [ICD9: 295; ICD10:F20]
|
Terminated |
[1]
|
Company |
Eisai Co Ltd
|
Structure |
|
Download
2D MOL
3D MOL
|
Canonical SMILES |
c1(c(c(cc(N2CCN(CC2)CCO)c1)[C@H](F)CC)Cl)c1c(C#N)cccc1.<br />Cl
|
CAS Number |
CAS 172732-21-7
|
Target and Pathway |
Target(s) |
5-HT 2 receptor |
Target Info |
Modulator |
[2]
|
D(3) dopamine receptor |
Target Info |
Modulator |
[2]
|
D(2) dopamine receptor |
Target Info |
Modulator |
[2]
|
KEGG Pathway
|
Calcium signaling pathway
|
Neuroactive ligand-receptor interaction
|
Gap junction
|
Serotonergic synapse
|
Inflammatory mediator regulation of TRP channelshsa04080:Neuroactive ligand-receptor interaction
|
Dopaminergic synapsehsa04015:Rap1 signaling pathway
|
cAMP signaling pathway
|
Dopaminergic synapse
|
Parkinson's disease
|
Cocaine addiction
|
Alcoholism
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Dopamine receptor mediated signaling pathway
|
Nicotine pharmacodynamics pathway
|
Reactome
|
Dopamine receptors
|
G alpha (i) signalling eventsR-HSA-390651:Dopamine receptors
|
G alpha (i) signalling events
|
WikiPathways
|
Monoamine GPCRs
|
GPCRs, Class A Rhodopsin-like
|
GPCR ligand binding
|
GPCR downstream signaling
|
Nicotine Activity on Dopaminergic Neurons
|
GPCRs, OtherWP666:Hypothetical Network for Drug Addiction
|
Genes and (Common) Pathways Underlying Drug Addiction
|
References |
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009126) |
---|
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009126) |